Related Experiment Video
Updated: May 5, 2026

08:45
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
1.9K
Is "intra-operating room" thromboelastometry useful in liver transplantation? A case-control study in 303 patients
Transplantation Proceedings
|December 10, 2013
Summary
Intraoperative thromboelastometry (orTEM) monitoring during liver transplantation (LT) reduces blood product use and complications. This technique improves patient survival and postoperative outcomes in liver graft recipients.
Area of Science:
- Hepatology
- Anesthesiology
- Transplantation Surgery
Background:
- Coagulation monitoring is crucial for minimizing blood loss during liver transplantation (LT).
- Thromboelastometry (TEM) is an established method for assessing coagulation parameters.
- The impact of intraoperative TEM (orTEM) on LT outcomes remains understudied.
Purpose of the Study:
- To investigate the association between orTEM and operative complications in LT recipients.
- To evaluate the effect of orTEM on long-term outcomes, including survival and postoperative complications.
- To determine if orTEM influences blood product utilization during LT.
Main Methods:
- A case-control study involving 303 liver graft recipients.
- Analysis of variables linked to operative complications and long-term LT outcomes.
- Comparison of outcomes between patients monitored with orTEM and those without.
Main Results:
- orTEM use was associated with reduced blood product transfusion in high-risk patients (MELD ≥ 21, retransplantation, high surgical difficulty, significant bleeding).
- Patients monitored with orTEM demonstrated improved survival rates.
- A lower incidence of postoperative complications was observed in the orTEM group.
Conclusions:
- Intraoperative thromboelastometry (orTEM) is a valuable tool in liver transplantation.
- orTEM facilitates reduced blood product usage and fewer postoperative complications.
- The implementation of orTEM can enhance overall outcomes and survival in liver transplant recipients.

